Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-003942
Filing Date
2025-01-28
Accepted
2025-01-28 13:07:05
Documents
86
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2504072
2 ex4-5.htm EX-4.5 25326
3 ex21-1.htm EX-21.1 5739
4 ex31-1.htm EX-31.1 11745
5 ex31-2.htm EX-31.2 12056
6 ex32-1.htm EX-32.1 6324
7 ex32-2.htm EX-32.2 6735
8 form10-k_001.jpg GRAPHIC 80976
9 form10-k_002.jpg GRAPHIC 95620
10 form10-k_003.jpg GRAPHIC 71516
11 form10-k_004.jpg GRAPHIC 229885
12 form10-k_005.jpg GRAPHIC 37614
13 form10-k_006.jpg GRAPHIC 83686
  Complete submission text file 0001493152-25-003942.txt   10675472

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE vtro-20241031.xsd EX-101.SCH 65163
15 XBRL CALCULATION FILE vtro-20241031_cal.xml EX-101.CAL 84759
16 XBRL DEFINITION FILE vtro-20241031_def.xml EX-101.DEF 233560
17 XBRL LABEL FILE vtro-20241031_lab.xml EX-101.LAB 510748
18 XBRL PRESENTATION FILE vtro-20241031_pre.xml EX-101.PRE 379277
89 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1183953
Mailing Address 3200 CHERRY CREEK DRIVE SOUTH SUITE 410 DENVER CO 80209
Business Address 3200 CHERRY CREEK DRIVE SOUTH SUITE 410 DENVER CO 80209 8558487627
Vitro Biopharma, Inc. (Filer) CIK: 0000793171 (see all company filings)

EIN.: 841012042 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-41766 | Film No.: 25562614
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)